L6 Strengthening the global drug control framework: a path to effective implementation E/CN.7/2025/L.6 Colombia: we updated the document to reflect all recent agreements from last night, we are still working hard with delegations to find consensus across the document Chair: We start with deliberating the title, the floor is open. Sudan: it was only …
Greece
CND Intersessional – Session 6 – Other Substantial Matters
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Other Substantial Matters proposed by Member States • Challenges to the identification of new illicit drugs: Discussion on strategies and approaches by laboratories to enhance the capacity of forensic personnel and harnessing technology to improve identification methods …
Item 6. Follow-up to the implementation at the national, regional and international levels of all commitments, as reflected in the Ministerial Declaration of 2019, to address and counter the world drug problem.
(…) UNODC: Thank you, Mr. Chair, distinguished delegates, ladies and gentlemen. It is my pleasure to brief the Commission on some of the significant efforts UNODC has undertaken over the last year to confront the global drug problem, in line with the Ministerial Declaration of 2019. Given time constraints, I will highlight just a few …
Item 3. High-level segment (Friday afternoon)
Bangladesh: H. E. Ambassador Johnson, Chair of the Commission on Narcotic Drugs at its 67th Session, H. E. Ghada Waly, Executive Director of the UNODC, Excellencies, Distinguished delegates, Ladies and Gentlemen, Good afternoon. I begin by congratulating Ambassador Johnson and other members of the bureau and assure them of our full support. Mr. Chair, We …
Opening of the 67th session of the Commission on Narcotic Drugs & Item 3. High-level segment (Thursday morning)
UN Web TV recording Opening of the 67th session of the Commission on Narcotic DrugsOutcome Document: High-level Declaration by the Commission on Narcotic Drugs on the 2024 midterm review, following up to the 2019 Ministerial DeclarationChair: Welcome. Inform you that for the opening session of the HLS, there’ll be a video transmission of the …
Side event. Innovation responses to promoting access to controlled medicines, while preventing diversion and non-medical use: Following up on the global “access and availability” campaign led by the chair of the 65th CND
Organised by Belgium with the support of Australia, Austria, Bulgaria, Croatia, Cyprus, Czechia, Denmark, El Salvador, Estonia, Finland, France, Germany, Ghana, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, the United States, the European Union, the UNODC Prevention, Treatment and Rehabilitation Section, the …